Imatinib mesylate (Gleevec) for disease relapse following allogeneic bone marrow transplantation.

被引：0
|
作者：
Soiffer, RJ [1 ]
Galinsky, I [1 ]
DeAngelo, D [1 ]
Alyea, EP [1 ]
Antin, JH [1 ]
Restas, D [1 ]
Stone, RM [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1682
引用
收藏
页码：400A / 400A
页数：1
相关论文
共 50 条
  • [21] Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation
    P Vandenberghe
    N Boeckx
    E Ronsyn
    R Decorte
    G Verhoef
    A Hagemeijer
    Leukemia, 2003, 17 : 458 - 460
  • [22] Bacteremia in patients undergoing allogeneic bone marrow transplantation.
    Gomez, E
    Sanchez, E
    Chavez, G
    Pizzuto, J
    BLOOD, 1997, 90 (10) : 4404 - 4404
  • [23] Bone marrow transfected with the IL-2 gene for reducing leukemic relapse following autologous bone marrow transplantation.
    Tam, YK
    Klingemann, HG
    BLOOD, 1997, 90 (10) : 4633 - 4633
  • [24] Appendicitis mimicking relapse of acute promyelocytic leukemia following allogeneic bone marrow transplantation
    Biro Adrienn
    Ternyik Laszlo
    Egyed Miklos
    Balint Istvan
    Czoma Veronika
    Kajtar Bela
    Kaposztas Zsolt
    ORVOSI HETILAP, 2020, 161 (51) : 2171 - 2174
  • [25] RELEVANCE OF CYTOGENETIC ANALYSIS IN LEUKEMIC RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    CLEMM, C
    WEGNER, RD
    KOLB, HJ
    MITTERMULLER, J
    WILMANNS, W
    BLUT, 1986, 53 (03): : 189 - 189
  • [26] KARYOTYPE AT RELAPSE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    SHAH, NK
    WAGNER, J
    SANTOS, G
    GRIFFIN, CA
    CANCER GENETICS AND CYTOGENETICS, 1992, 61 (02) : 183 - 192
  • [27] The presence of a caregiver is a powerful prognostic variable of survival following allogeneic bone marrow transplantation.
    Bolwell, BJ
    Foster, L
    McLellan, L
    Hsu, A
    Sissano, D
    Kuczkowski, E
    Jarvis, J
    Sands, K
    Serafin, M
    Curtis, J
    Lichtin, A
    Andresen, S
    Pohlman, B
    Kalaycio, M
    Sobecks, R
    BLOOD, 2001, 98 (11) : 202A - 202A
  • [28] Sex steroid ablation enhances immune reconstitution following allogeneic bone marrow transplantation.
    Goldberg, GL
    Alpdogan, O
    Muriglan, SJ
    Willis, LM
    Greenberg, AS
    Boyd, RL
    van den Brink, MRM
    BLOOD, 2002, 100 (11) : 406A - 406A
  • [29] TPO regulation following bone marrow transplantation.
    Meng, YG
    Martin, TG
    Peterson, ML
    Shuman, MA
    Cohen, RL
    Wong, WL
    BLOOD, 1995, 86 (10) : 1237 - 1237
  • [30] Donor lymphocyte infusion for treatment of hematological leukemia relapse in children after allogeneic bone marrow transplantation.
    Pieczonka, A
    Wachowiak, J
    Boruczkowski, D
    Leda, M
    Jólkowska, J
    Ladoñ, D
    Witt, M
    BONE MARROW TRANSPLANTATION, 2002, 30 : S63 - S63
12345